Q1 2021 Aziyo Biologics Inc Earnings Call Transcript
Welcome to the Aziyo Biologics Q1 2021 Earnings Call. My name is Adrienne, and I'll be your operator for today's call. (Operator Instructions)
I'll now turn the call over to Leigh Salvo, Investor Relations. Leigh, you may begin.
Thank you, and thank you all for participating in today's call. Joining me are Ron Lloyd, Chief Executive Officer; and Matt Ferguson, Chief Financial Officer.
Earlier today, Aziyo released financial results for the first quarter ended March 31, 2021. A copy of the press release is available on the company's website.
Before we begin, I'd like to remind you that management will make statements during this call that include forward-looking statements within the meaning of federal securities laws which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any statements contained in this call that do not relate to matters of historical fact or relate to expectations or predictions of future events, results or performance
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |